• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
    • Why Should You Support SAGES?
    • SAGES Swag
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Annual Meeting
      • 2027 Scientific Session Call for Abstracts
      • 2027 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • SAGES Lead Up Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • Innovative Surgical Trends
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Advanced Laparoscopy and Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
    • Foregut Video Atlas
  • Opportunities
    • Join the SAGES Patient Partner Network (PPN)
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs
  • Learning Hub
You are here: Home / Abstracts / The Impact of Proton Pump Inhibitors on Intra-peritoneal Sepsis:

The Impact of Proton Pump Inhibitors on Intra-peritoneal Sepsis:

Study Aim: Proton pump inhibitors (PPI) are commonly given for the treatment of GERD and ulcer disease. In many non-operative cases of perforated ulcer disease, it is standard of care. During transgastric NOTES procedures there is an iatrogenic perforation of the gastric wall with leakage of gastric contents into the peritoneal cavity. Our study aim is to determine the effect of proton pump inhibitors and alterations in gastric pH on infection rates during transgastric surgery.
Methods: Thirty 250 g male Sprague-Dawley rats were divided to a study group N=15 and a control group N=15. In the study group rats were given 5mg/kg of pantoprazole SQ daily for three days before procedure and another dose one hour before. The control group received 3cc of SQ saline at similar time points. A mini-laparotomy with gastrotomy and aspiration of 2.0cc of gastric contents were injected into the peritoneal cavity of both groups of rats. Intra-gastric pH and intra-peritoneal pH was measured using a needle probe and pH meter. Rats were returned to their cages and given food and water ad libitum. White cell counts were obtained on post-operative day 1, 3, 7 and 14. At necropsy aerobic and anaerobic cultures were obtained using culture swab of the peritoneal cavity.
Results: There were no deaths in either group. The average intra-gastric pH in the study group was 5.13 vs. 3.26 (p= 0.03) in the control group. The average intra-peritoneal pH was similar in both groups 7.09 vs. 7.19 (p=.34). The white blood count in the study group increased by an average of 4.5 vs. 3.5 (1000 cells/mm) in the control group. Bacterial cultures were positive in 3/15 (20%) rats in the control group and 9/15 (60%) in the group treated with PPI (P=0.008). Intra-abdominal abscesses were found in 2/15 (13%) rats in the control group and 5/15 (33%) in the group treated with PPI (p=0.08). The most common isolate in the rat cultures were E-Coli, Proteus and Staphlococcus Xylosus. There was a higher rate of E-Coli infection in the PPI group 8/9 (88%) vs. the control group 1/3 (33%).
Conclusions: Pre-treatment of a rat model for transgastric NOTES procedures with a proton pump inhibitor resulted in a higher rate of peritoneal bacterial contamination and abscess formation. The acidic environment of the stomach appears to be protective against infection when intra-peritoneal contamination occurs as a result of gastrotomy. PPI’s may increase infectious complications in NOTES patients

THIS STUDY SUPPORTED BY A NOSCAR GRANT


Session: Podium Presentation

Program Number: S031

Related



Hours & Info

15821 Ventura Blvd Ste 400
Encino, CA 91436

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2026 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

Refine Search